Sign in

You're signed outSign in or to get full access.

Robert Favera

Research Analyst at Capital Management

Robert Favera is an Equity Analyst at Capital Management, specializing in financial sector research with a particular focus on large-cap U.S. banks and insurance companies such as JPMorgan Chase, Bank of America, and Prudential Financial. He is recognized for maintaining a success rate of approximately 65% with an average annualized return of 8% on his published recommendations, earning positive feedback from industry platforms. Favera began his career as a junior analyst at Franklin Partners in 2012 and advanced through roles at Grantley Advisors before joining Capital Management in 2018. He holds FINRA Series 7 and 63 licenses and is a Chartered Financial Analyst (CFA), reflecting his commitment to analytical rigor and industry best practices.

Robert Favera's questions to AstroNova (ALOT) leadership

Question · Q3 2025

Robert Favera from Capital Management asked for a breakdown of MTEX's expenses, inquired if delayed Boeing orders impacted Test & Measurement segment margins, and questioned if product mix drove the sequential decline in Product Identification segment margins.

Answer

Executive Thomas DeByle provided a detailed breakdown of MTEX's quarterly expenses from the press release, including selling, R&D, and G&A costs. Executive Gregory Woods confirmed that delayed, high-margin Boeing orders negatively affected T&M margins and that a significant delayed order was the primary factor in the PI segment's margin decline due to product mix.

Ask follow-up questions

Fintool

Fintool can predict AstroNova logo ALOT's earnings beat/miss a week before the call